2025 SPEAKERS

Kevyn Adler, Senior Director, Market Access Product & Pipeline Strategy, Regeneron

Ana Filipa Alexandre, Former Vice President, Head of Pricing and Market Access, Santen

Ana Filipa Alexandre | Former Vice President, Head of Pricing and Market Access | Santen » speaking at World EPA Congress

Eunice Alvazzi, Head of Global Value & Access, Hematology, Nephrology & Neurology,, Alexion – AstraZeneca Rare Disease

Eunice Alvazzi | Head of Global Value & Access, Hematology, Nephrology & Neurology, | Alexion – AstraZeneca Rare Disease » speaking at World EPA Congress

Marta Andreykiv, Head of Market Access Europe, Viatris

Marta Andreykiv | Head of Market Access Europe | Viatris » speaking at World EPA Congress

Luigi Angelillo, Director, Market Access EMEA, Argenx

Luigi Angelillo | Director, Market Access EMEA | Argenx » speaking at World EPA Congress

Ad Antonisse, Director, Market Access & Corporate Affairs, AstraZeneca

Ad Antonisse | Director, Market Access & Corporate Affairs | AstraZeneca » speaking at World EPA Congress

Jose Aragunde, Value and Pricing Strategy Lead, Market Access, Novartis

Jose Aragunde | Value and Pricing Strategy Lead, Market Access | Novartis » speaking at World EPA Congress

Jorge Arellano, Vice President, Head of Intercontinental Markets, Market Access, Pricing, & Value Demonstration, Bristol Myers Squibb

Jorge Arellano | Vice President, Head of Intercontinental Markets, Market Access, Pricing, & Value Demonstration | Bristol Myers Squibb » speaking at World EPA Congress

Marnix Artz, Head, Patient Access, Pricing & Governmental Affairs, Merck Group

Marnix Artz | Head, Patient Access, Pricing & Governmental Affairs | Merck Group » speaking at World EPA Congress

Johnny Bane, Head of Market Access, Accord Healthcare

Johnny Bane | Head of Market Access | Accord Healthcare » speaking at World EPA Congress

Tomer Benzaken, Director, Head of Commercial Operations & Trade, Astellas

Tomer Benzaken | Director, Head of Commercial Operations & Trade | Astellas » speaking at World EPA Congress

Katja Berg, Global Director, Innovative Value and Access Strategy, Global Market Access and Pricing, BBU, AstraZeneca

Katja Berg | Global Director, Innovative Value and Access Strategy, Global Market Access and Pricing, BBU | AstraZeneca » speaking at World EPA Congress

Chris Bidad, Global Head, Access Strategy and Payer Policy, AstraZeneca

Matthias Bischof, Senior Director, International Health Economics, Novartis

Matthias Bischof | Senior Director, International Health Economics | Novartis » speaking at World EPA Congress

Marie-Sharmila Blandino, Global Access Strategy Lead, Amgen

Marie-Sharmila Blandino | Global Access Strategy Lead | Amgen » speaking at World EPA Congress

Thomas Bols, Head of Government Affairs and Patient Advocacy, EMEA, PTC Therapeutics

Thomas Bols | Head of Government Affairs and Patient Advocacy, EMEA | PTC Therapeutics » speaking at World EPA Congress

Kinga Borsos, Vice President, Head of US HEOR, Boehringer Ingelheim

Kinga Borsos | Vice President, Head of US HEOR | Boehringer Ingelheim » speaking at World EPA Congress

Meindert Boysen, Independent HTA Expert & Chair, HTAi Global Policy Forum

Vidya Breeveld, CEO, Transmineo

Chiara Brouns, Strategic purchaser, Zorgverzekeraars Nederland

Chiara Brouns | Strategic purchaser | Zorgverzekeraars Nederland » speaking at World EPA Congress

Tom Burke, Scientific Associate Vice President, CORE, MSD

Tom Burke | Scientific Associate Vice President, CORE | MSD » speaking at World EPA Congress

Robert Burley, Director, Care, Campaigns and Support, The Muscular Dystrophy U.K.

Robert Burley | Director, Care, Campaigns and Support | The Muscular Dystrophy U.K. » speaking at World EPA Congress

Astrid Buys, Global Head of Tenders & Pricing, Bavarian Nordic

Astrid Buys | Global Head of Tenders & Pricing | Bavarian Nordic » speaking at World EPA Congress

Silvia Miriam CAMMARATA, Senior Regulatory Affairs and Health Policy Specialist, AIFA Italian Medicine Agency

Silvia Miriam CAMMARATA | Senior Regulatory Affairs and Health Policy Specialist | AIFA Italian Medicine Agency » speaking at World EPA Congress

Gorana Capkun, Vice President, Global Head of Patient Focused Real World Evidence, Merck Group

Gorana Capkun | Vice President, Global Head of Patient Focused Real World Evidence | Merck Group » speaking at World EPA Congress

Lorenzo Capretto, Market Access Lead EU&EM, Global Rare Disease, Chiesi Farmaceutici SpA

Lorenzo Capretto | Market Access Lead EU&EM, Global Rare Disease | Chiesi Farmaceutici SpA » speaking at World EPA Congress

Laurent Carter, Senior Vice President, Head of Global Pricing, Bristol-Myers Squibb

Laurent Carter | Senior Vice President, Head of Global Pricing | Bristol-Myers Squibb » speaking at World EPA Congress

Sandro Cesaro, Head of Europe Market Access & Pricing, AstraZeneca

Sandro Cesaro | Head of Europe Market Access & Pricing | AstraZeneca » speaking at World EPA Congress

Helene Chevrou-Severac, Senior Director, RWE & Outcomes Centre of Excellence Head, Alexion – AstraZeneca Rare Disease

Helene Chevrou-Severac | Senior Director, RWE & Outcomes Centre of Excellence Head | Alexion – AstraZeneca Rare Disease » speaking at World EPA Congress

Sally Chung, Vice President, Head of Market Access & Pricing Europe, GSK

Sally Chung | Vice President, Head of Market Access & Pricing Europe | GSK » speaking at World EPA Congress

Stephen Connell, Senior Director, Global Pricing & Market Access - Gene Therapy, Pfizer

Stephen Connell | Senior Director, Global Pricing & Market Access - Gene Therapy | Pfizer » speaking at World EPA Congress

Warren Cowell, Director, Market Access UK, Shionogi Ltd

Warren Cowell | Director, Market Access UK | Shionogi Ltd » speaking at World EPA Congress

Don Creighton, Executive Director, Market Access Pipeline and Readiness Lead, Regeneron

Don Creighton | Executive Director, Market Access Pipeline and Readiness Lead | Regeneron » speaking at World EPA Congress

Nidhi Dani, Director, Global Market Access, GSK

Nidhi Dani | Director, Global Market Access | GSK » speaking at World EPA Congress

Michele de Guise, President and Chief Executive Officer, INESSS

Michele de Guise | President and Chief Executive Officer | INESSS » speaking at World EPA Congress

Marie-Monique de Molliens, Global Market Access Horizon Scanning Senior Director, Sanofi

Marie-Monique de Molliens | Global Market Access Horizon Scanning Senior Director | Sanofi » speaking at World EPA Congress

Emanuele Degortes, Vice President, Global Head of Access Policy and Patient Advocacy, Menarini

Emanuele Degortes | Vice President, Global Head of Access Policy and Patient Advocacy | Menarini » speaking at World EPA Congress

Rossella Di Bidino, Head of HTA for AI Unit, Graduate School of Health Economics and Management ALTEMS

Rossella Di Bidino | Head of HTA for AI Unit | Graduate School of Health Economics and Management ALTEMS » speaking at World EPA Congress

Toon Digneffe, Head, Public Affairs & Public Policy, Europe & Canada, Takeda

Toon Digneffe | Head, Public Affairs & Public Policy, Europe & Canada | Takeda » speaking at World EPA Congress

Riad Dirani, Vice President, Global Health Economics, Value and Outcomes, Teva Pharmaceuticals

Riad Dirani | Vice President, Global Health Economics, Value and Outcomes | Teva Pharmaceuticals » speaking at World EPA Congress

Patricia Dorling, Vice President, Head, Global HEOR and Real World Evidence, Chiesi Group

Patricia Dorling | Vice President, Head, Global HEOR and Real World Evidence | Chiesi Group » speaking at World EPA Congress

Maurice Driessen, Senior Director, Head of Inline Brands, GHEVO, Teva Pharmaceuticals

Maurice Driessen | Senior Director, Head of Inline Brands, GHEVO | Teva Pharmaceuticals » speaking at World EPA Congress

Marcus Droege, Senior Advisor, Market Access & Commercial, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs

Marcus Droege | Senior Advisor, Market Access & Commercial | EUCOPE - European Confederation of Pharmaceutical Entrepreneurs » speaking at World EPA Congress

Claire Everitt, Design Engineering Team Lead, IMI Project Leader, PFizer

Claire Everitt | Design Engineering Team Lead, IMI Project Leader | PFizer » speaking at World EPA Congress

Gina Ewy, VP Global Market Access, Hansa Biopharma

Gina Ewy | VP Global Market Access | Hansa Biopharma » speaking at World EPA Congress

Marina Faiella, Head, Forecasting and Business Analytics, Europe, BeiGene

Marina Faiella | Head, Forecasting and Business Analytics, Europe | BeiGene » speaking at World EPA Congress

Lora Fleifel, Director, Market Access Operations, Oncology Europe, Merck

Lora Fleifel | Director, Market Access Operations, Oncology Europe | Merck » speaking at World EPA Congress

Steven Flostrand, Executive Director, Value, Access & Pricing, Incyte Corp.

Steven Flostrand | Executive Director, Value, Access & Pricing | Incyte Corp. » speaking at World EPA Congress

Martina Garau, Director, Office of Health Economics

Martina Garau | Director | Office of Health Economics » speaking at World EPA Congress

Loic Gauthier, Director, Market Access and Pricing, Intercontinental Region, CSL Behring

Loic Gauthier | Director, Market Access and Pricing, Intercontinental Region | CSL Behring » speaking at World EPA Congress

Philippe Ghyssels, Vice President, Global Public Affairs, Ipsen

Philippe Ghyssels | Vice President, Global Public Affairs | Ipsen » speaking at World EPA Congress

Mathieu Gilbert, Chief Operating Officer, Adocia

Mathieu Gilbert | Chief Operating Officer | Adocia » speaking at World EPA Congress

Christoph Glaetzer, Chief Global Value and Access Officer, Johnson & Johnson

Christoph Glaetzer | Chief Global Value and Access Officer | Johnson & Johnson » speaking at World EPA Congress

Tristan Gloede, Executive Director, Global Head of Market Access Retinal Health, Boehringer Ingelheim

Tristan Gloede | Executive Director, Global Head of Market Access Retinal Health | Boehringer Ingelheim » speaking at World EPA Congress

Wim Goettsch, Special Advisor HTA & Professor for HTA of Pharmaceuticals, Zorginstituut & Utrecht University

Jean Christophe Goirand, Senior Director, Global Head Market Access & Pricing, Essential Pharma

Jean Christophe Goirand | Senior Director, Global Head Market Access & Pricing | Essential Pharma » speaking at World EPA Congress

Sofiya Got, Chief Scientific Officer, Action Duchenne

Sofiya Got | Chief Scientific Officer | Action Duchenne » speaking at World EPA Congress

Sylvie Greneche, Head of Global Market Access, General Medicines, Sanofi

Sylvie Greneche | Head of Global Market Access, General Medicines | Sanofi » speaking at World EPA Congress

Thomas Grub, Senior Expert, Global Pricing and Market Access, Medac GmbH

Thomas Grub | Senior Expert, Global Pricing and Market Access | Medac GmbH » speaking at World EPA Congress

Neil Grubert, Global Market Access Expert, Independent

Neil Grubert | Global Market Access Expert | Independent » speaking at World EPA Congress

Josep M Guiu, Director, Pharmacy and Medicines Area, Consortium of health and social care of Catalonia

Josep M Guiu | Director, Pharmacy and Medicines Area | Consortium of health and social care of Catalonia » speaking at World EPA Congress

Marlene Gyldmark, Vice President, Head, Global Access Evidence, Idorsia

Marlene Gyldmark | Vice President, Head, Global Access Evidence | Idorsia » speaking at World EPA Congress

Matthew Hanchard, Research Fellow, University of Sheffield

Günter Harms, Senior Director, Patient Access, Germany, Austria, Switzerland, Novartis Gene Therapies

Günter Harms | Senior Director, Patient Access, Germany, Austria, Switzerland | Novartis Gene Therapies » speaking at World EPA Congress

Patrick Hopkinson, Vice President, GHEOR, International Markets and HTA Strategy, Bristol-Myers Squibb

Patrick Hopkinson | Vice President, GHEOR, International Markets and HTA Strategy | Bristol-Myers Squibb » speaking at World EPA Congress

Kirsty Hoyle, Chief Executive Officer, Metabolic Support UK

Dawn Ireland, President & Founder, CDH International

Dawn Ireland | President & Founder | CDH International » speaking at World EPA Congress

Jayasree Iyer, Chief Executive Officer, Access to Medicine Foundation

Jayasree Iyer | Chief Executive Officer | Access to Medicine Foundation » speaking at World EPA Congress

Daniel Jackson, Global Head, Market Access Policy, UCB

Daniel Jackson | Global Head, Market Access Policy | UCB » speaking at World EPA Congress

Manel Juan, Head of Immunology Service, Hospital Clínic de Barcelona

Manel Juan | Head of Immunology Service | Hospital Clínic de Barcelona » speaking at World EPA Congress

Madhu Kabra, Global Director, Health Economics and Outcomes Research, MKGlobal

Madhu Kabra | Global Director, Health Economics and Outcomes Research | MKGlobal » speaking at World EPA Congress

Lisette Kaskens, Director Market Access, Ferring Pharmaceuticals

Lisette Kaskens | Director Market Access | Ferring Pharmaceuticals » speaking at World EPA Congress

Angie Kehagia, Deputy Director, Senior HTA, KiTEC King's Technology Evaluation Centre

Angie Kehagia | Deputy Director, Senior HTA | KiTEC King's Technology Evaluation Centre » speaking at World EPA Congress

Sebastian Kessel, Senior Director, Head of Market Access & Public Affairs, Germany, UCB

Sebastian Kessel | Senior Director, Head of Market Access & Public Affairs, Germany | UCB » speaking at World EPA Congress

Sandeep Kiri, Global Head, Health Economics and HTA Evidence, UCB

Sandeep Kiri | Global Head, Health Economics and HTA Evidence | UCB » speaking at World EPA Congress

Sven Klijn, Director, HEOR Economic & Predictive Modeling, Bristol Myers Squibb

Jolanda Koenders, Head of New Product Planning, Central Southeast Europe, Takeda

Jolanda Koenders | Head of New Product Planning, Central Southeast Europe | Takeda » speaking at World EPA Congress

Hannah Kurth, Founder and Managing Director, Pulse Edge

Hannah Kurth | Founder and Managing Director | Pulse Edge » speaking at World EPA Congress

Marianne Laouri, Executive Director, Global Asset Lead, Retinal Health, Boehringer Ingelheim

Marianne Laouri | Executive Director, Global Asset Lead, Retinal Health | Boehringer Ingelheim » speaking at World EPA Congress

Walmon Leal, Vice President, Head of Global Pricing, Tenders & Contract, Viatris

Walmon Leal | Vice President, Head of Global Pricing, Tenders & Contract | Viatris » speaking at World EPA Congress

Pauline L'Hénaff, Head of Industry Engagement, Access to Medicine Foundation

Pauline L'Hénaff | Head of Industry Engagement | Access to Medicine Foundation » speaking at World EPA Congress

Manuela Machado, Global Payer Strategy Solutions Lead, UCB

Manuela Machado | Global Payer Strategy Solutions Lead | UCB » speaking at World EPA Congress

Joerg Mahlich, Market Access and Government Affairs Lead, Miltenyi Biomedicine GmbH

Joerg Mahlich | Market Access and Government Affairs Lead | Miltenyi Biomedicine GmbH » speaking at World EPA Congress

Bill Malcolm, Executive Director, Global HEOR Economic & Predictive Modelling, BMS

Bill Malcolm | Executive Director, Global HEOR Economic & Predictive Modelling | BMS » speaking at World EPA Congress

Chris Mancill, Senior Vice President, Head, Global Market Access, Pricing, and Value Demonstration, Bristol Myers Squibb

Alen Marijam, Senior Director, Vaccines, HEOR and Epidemiology Lead, Europe, GSK

Alen Marijam | Senior Director, Vaccines, HEOR and Epidemiology Lead, Europe | GSK » speaking at World EPA Congress

Vanessa Mirsky, Vice President, Life Sciences Data Strategy, OneOncology

Lorenzo Montrasio, Member of Volrethics Steering Committee, Former Council of Europe

Paolo Morgese, Vice President, Public Affairs, Europe, Alliance for Regenerative Medicine

Paolo Morgese | Vice President, Public Affairs, Europe | Alliance for Regenerative Medicine » speaking at World EPA Congress

Philippe Mourouga, Vice President, International Partner Markets, Biogen

Philippe Mourouga | Vice President, International Partner Markets | Biogen » speaking at World EPA Congress

Michael Mueller, Head of Market Access, Western Europe, Sun Pharma

Michael Mueller | Head of Market Access, Western Europe | Sun Pharma » speaking at World EPA Congress

Alexander Natz, Secretary General, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs

Andrew Olaye, Head of EMEA Market Access, Orchard Therapeutics Ltd

Andrew Olaye | Head of EMEA Market Access | Orchard Therapeutics Ltd » speaking at World EPA Congress

Melvin Skip Olson, Founder, Olson Strategies GmbH

Wija Oortwijn, Chair of Appraisal Committee at ZINL & Assistant Professor, HTA, ZIN & Radboud University Medical Center

Wija Oortwijn | Chair of Appraisal Committee at ZINL & Assistant Professor, HTA | ZIN & Radboud University Medical Center » speaking at World EPA Congress

Loubna Ouriaghli, Head of Government Affairs and Policy, Ipsen

Loubna Ouriaghli | Head of Government Affairs and Policy | Ipsen » speaking at World EPA Congress

Ipek Ozer-Stillman, Vice President, Global Head, Health Economics, Takeda

Ipek Ozer-Stillman | Vice President, Global Head, Health Economics | Takeda » speaking at World EPA Congress

Robert Palmer, Head of Access, Oncology, Boehringer Ingelheim

Robert Palmer | Head of Access, Oncology | Boehringer Ingelheim » speaking at World EPA Congress

Elena Panitti, Global Director, Evidence Valuation and Enablement, Novartis

Elena Panitti | Global Director, Evidence Valuation and Enablement | Novartis » speaking at World EPA Congress

Michela Pantaleoni, Chief Market Access Officer, Napo Therapeutics

Michela Pantaleoni | Chief Market Access Officer | Napo Therapeutics » speaking at World EPA Congress

Lucia Paone, Senior Director, Market Access Product & Pipeline Strategy, Regeneron

Lucia Paone | Senior Director, Market Access Product & Pipeline Strategy | Regeneron » speaking at World EPA Congress

Lotta Parviainen, Head of Global Market Access, Zambon France

Lotta Parviainen | Head of Global Market Access | Zambon France » speaking at World EPA Congress

Dilip Patel, Vice President, Pricing, Value and Access, Autolus

Dilip Patel | Vice President, Pricing, Value and Access | Autolus » speaking at World EPA Congress

Julien Patris, Head of Patient Advocacy, Public Policy, Corporate Communications, EMEA, arGEN-X

Julien Patris | Head of Patient Advocacy, Public Policy, Corporate Communications, EMEA | arGEN-X » speaking at World EPA Congress

Tomaso Piaggio, Head of Southern Cluster, International Market Access, Alnylam Pharmaceuticals

Tomaso Piaggio | Head of Southern Cluster, International Market Access | Alnylam Pharmaceuticals » speaking at World EPA Congress

Trine Pilgaard, Director, Head of Market Access, Denmark and Iceland, Pfizer

Trine Pilgaard | Director, Head of Market Access, Denmark and Iceland | Pfizer » speaking at World EPA Congress

Oresta Piniazhko, Director of HTA Department, State Expert Centre of the Ministry of Health of Ukraine

Oresta Piniazhko | Director of HTA Department | State Expert Centre of the Ministry of Health of Ukraine » speaking at World EPA Congress

Carme Pinyol, Early Products and HEOR Lead, Novartis

Lara Pippo, Head of Market Access & Government Affairs, Italy, CSL Behring

Lara Pippo | Head of Market Access & Government Affairs, Italy | CSL Behring » speaking at World EPA Congress

Ana Plata, Head of Global Access, Respiratory & Immunology, AstraZeneca

Ana Plata | Head of Global Access, Respiratory & Immunology | AstraZeneca » speaking at World EPA Congress

Julie Powell, Director, Patient Advocacy and Public Affairs, Pleco Therapeutics

Julie Powell | Director, Patient Advocacy and Public Affairs | Pleco Therapeutics » speaking at World EPA Congress

Annette Powers, Senior Vice President, Global Market Access, Bristol Myers Squibb

Annette Powers | Senior Vice President, Global Market Access | Bristol Myers Squibb » speaking at World EPA Congress

Arup Pramanik, Corporate Vice President, Head of Global Market Access, TA Inflammation, Boehringer Ingelheim

Arup Pramanik | Corporate Vice President, Head of Global Market Access, TA Inflammation | Boehringer Ingelheim » speaking at World EPA Congress

Chris Prins, Policy Advisor Expensive Medicines, Zorgverzekeraars Nederland

Chris Prins | Policy Advisor Expensive Medicines | Zorgverzekeraars Nederland » speaking at World EPA Congress

Jennifer Quinn, Head of Global Value and Access, Debiopharm International

Jennifer Quinn | Head of Global Value and Access | Debiopharm International » speaking at World EPA Congress

Marco Rauland, Vice President, Market Access, Strategy, Pricing and Analytics, Merck Group

Marco Rauland | Vice President, Market Access, Strategy, Pricing and Analytics | Merck Group » speaking at World EPA Congress

Laurene Redding, Global Head, Value, Access & Pricing, BeiGene

Laurene Redding | Global Head, Value, Access & Pricing | BeiGene » speaking at World EPA Congress

Vijay Reddy, Chief Commercial Officer, Avinya Biotech

Vijay Reddy | Chief Commercial Officer | Avinya Biotech » speaking at World EPA Congress

Casey Rhode, Senior Vice President, Corporate Strategy, OneOncology

Casey Rhode | Senior Vice President, Corporate Strategy | OneOncology » speaking at World EPA Congress

Florence Robson-Barkats, Head of Patient Engagement, NHS Improvement

Florence Robson-Barkats | Head of Patient Engagement | NHS Improvement » speaking at World EPA Congress

Sandrine Ruiz, Senior Director, Market Access, Pricing & HEOR, Immunocore Ltd

Sandrine Ruiz | Senior Director, Market Access, Pricing & HEOR | Immunocore Ltd » speaking at World EPA Congress

Claus Runge, Senior Vice President, Global Head of Market Access, Public Affairs & Sustainability, Bayer

Claus Runge | Senior Vice President, Global Head of Market Access, Public Affairs & Sustainability | Bayer » speaking at World EPA Congress

Geraldine Rylander, Director, Global Market Access, Psychiatry & Pipeline, Lundbeck

Geraldine Rylander | Director, Global Market Access, Psychiatry & Pipeline | Lundbeck » speaking at World EPA Congress

Marie Sanderson, Head of Value and Access, Innovative Medicine, Novartis

Marie Sanderson | Head of Value and Access, Innovative Medicine | Novartis » speaking at World EPA Congress

Steve Sandor, Vice President, Market Access, Government Affairs and Trade, Paratek Pharmaceuticals , Inc.

Steve Sandor | Vice President, Market Access, Government Affairs and Trade | Paratek Pharmaceuticals , Inc. » speaking at World EPA Congress

Thilo Schaufler, Global Head, Health Economics and Outcomes Research, CSL Vifor

Thilo Schaufler | Global Head, Health Economics and Outcomes Research | CSL Vifor » speaking at World EPA Congress

Fabian Schmidt, Global Head of Market Access, HEOR and Policy, Recordati Rare Diseases

Fabian Schmidt | Global Head of Market Access, HEOR and Policy | Recordati Rare Diseases » speaking at World EPA Congress

Mette Schrøder Hemels, Vice President, Global Payer Evidence, Portfolio Strategy, Access & Pricing, Novo Nordisk A/S

Mette Schrøder Hemels | Vice President, Global Payer Evidence, Portfolio Strategy, Access & Pricing | Novo Nordisk A/S » speaking at World EPA Congress

Ayman Semaan, Market Access & Pricing Lead, Biologix

Shuvayu Sen, Vice President, Head of Oncology, Center of Observational & Real-World Evidence, Merck & Co., Inc.

Shuvayu Sen | Vice President, Head of Oncology, Center of Observational & Real-World Evidence | Merck & Co., Inc. » speaking at World EPA Congress

Hans Severens, Independent HTA Expert, Severens HTA Consultancy

Hans Severens | Independent HTA Expert | Severens HTA Consultancy » speaking at World EPA Congress

Diana Sinkevich, Head of Access, EU & International, Global Rare Diseases, Chiesi

Diana Sinkevich | Head of Access, EU & International, Global Rare Diseases | Chiesi » speaking at World EPA Congress

Matt Slabbert, Vice President, Global Head of Pharma Public Affairs, Bayer

Matt Slabbert | Vice President, Global Head of Pharma Public Affairs | Bayer » speaking at World EPA Congress

Najib Slassi, Director, Global Product Strategy, Novartis

Najib Slassi | Director, Global Product Strategy | Novartis » speaking at World EPA Congress

Jiri Smejkal, Global Head of Pricing and Tender Excellence for PDT, Takeda

Jiri Smejkal | Global Head of Pricing and Tender Excellence for PDT | Takeda » speaking at World EPA Congress

Igor Solev, Global Head, Market Access, Policy & External Payer Affairs, Abbott Laboratories

Igor Solev | Global Head, Market Access, Policy & External Payer Affairs | Abbott Laboratories » speaking at World EPA Congress

Seema Sondhi, Head, Payer Value & Access, Takeda

Seema Sondhi | Head, Payer Value & Access | Takeda » speaking at World EPA Congress

Ulf Staginnus, Vice President, International Market Access & Pricing, Blueprint Medicines

Ulf Staginnus | Vice President, International Market Access & Pricing | Blueprint Medicines » speaking at World EPA Congress

Lotte Steuten, Deputy CEO, Office of Health Economics

Rachel Studer, Global Evidence Executive Director, Oncology & Immunology, Novartis

Rachel Studer | Global Evidence Executive Director, Oncology & Immunology | Novartis » speaking at World EPA Congress

Meni Styliadou, Vice President, Health Data Partnerships, Data Science Institute, Takeda Pharmaceuticals International AG

Jan Swiderski, Director, Head of Global Public Affairs and Advocacy, Ipsen

Jan Swiderski | Director, Head of Global Public Affairs and Advocacy | Ipsen » speaking at World EPA Congress

Elena Tricca, Vice President, Global Market Access and Pricing, BioPharmaceuticals, AstraZeneca

Elena Tricca | Vice President, Global Market Access and Pricing, BioPharmaceuticals | AstraZeneca » speaking at World EPA Congress

Emmanouil Tsiasiotis, Research Project Manager and Coordinator, EDiHTA

Emmanouil Tsiasiotis | Research Project Manager and Coordinator | EDiHTA » speaking at World EPA Congress

Aodan Tynan, Vice President, Global Market Access, Astellas

Aodan Tynan | Vice President, Global Market Access | Astellas » speaking at World EPA Congress

Bart Van Den Daele, Director, Market Access, Head of External Affairs, Gilead Sciences

Bart Van Den Daele | Director, Market Access, Head of External Affairs | Gilead Sciences » speaking at World EPA Congress

Goedele van Haasteren, Deputy Chief of the HTA department, Federal Office of Public Health, Switzerland

Goedele van Haasteren | Deputy Chief of the HTA department | Federal Office of Public Health, Switzerland » speaking at World EPA Congress

Chantal van Litsenburg, Manager, Translational Effectiveness, Leiden University Medical Center (Netherlands)

Chantal van Litsenburg | Manager, Translational Effectiveness | Leiden University Medical Center (Netherlands) » speaking at World EPA Congress

Matthijs Van Meerveld, Associate Vice President, Global Head of Access Policy & Patient Advocacy, Oncology, Menarini Stemline

Matthijs Van Meerveld | Associate Vice President, Global Head of Access Policy & Patient Advocacy, Oncology | Menarini Stemline » speaking at World EPA Congress

Mary Lynne van Poelgeest-Pomfret, President, World Federation for Incontinence and Pelvic Problems (WFIPP)

Mary Lynne van Poelgeest-Pomfret | President | World Federation for Incontinence and Pelvic Problems (WFIPP) » speaking at World EPA Congress

Kärt Veliste, Service Manager, Department of Medicines and Medical Devices, Tervisekassa Estonian Health Insurance Fund

Kärt Veliste | Service Manager, Department of Medicines and Medical Devices | Tervisekassa Estonian Health Insurance Fund » speaking at World EPA Congress

Reg Waldeck, Vice President, Oncology Market Access Strategy Leader, Bayer

Reg Waldeck | Vice President, Oncology Market Access Strategy Leader | Bayer » speaking at World EPA Congress

Alexander Wilke, Senior Director, Global Market Access and Pricing, Norgine

Alexander Wilke | Senior Director, Global Market Access and Pricing | Norgine » speaking at World EPA Congress

Amy Winnen, Consultant, Independent Market Access Expert

Schiffon Wong, Vice President and Head, Neurology & Immunology, Global Value Demonstration, EMD Serono

Keir Woods, Vice President, Global Value Demonstration, Market Access & Pricing (GVAP), Oncology, Merck Group

Keir Woods | Vice President, Global Value Demonstration, Market Access & Pricing (GVAP), Oncology | Merck Group » speaking at World EPA Congress

Gergana Zlateva, Vice President, Global Access & Pricing, Oncology, Pfizer

Gergana Zlateva | Vice President, Global Access & Pricing, Oncology | Pfizer » speaking at World EPA Congress

Korab Zuka, Vice President, Corporate Affairs, Purpose Communications and ESG, Bristol Myers Squibb

Korab Zuka | Vice President, Corporate Affairs, Purpose Communications and ESG | Bristol Myers Squibb » speaking at World EPA Congress

Get Involved 
 

Sponsorship & Exhibition Sales


David Boore 
david.boore@terrapinn.com
+44 20 8164 3052

Conference Production


George Mullens
george.mullens@terrapinn.com
+44 20 8164 3940

Marketing Opportunities


Karen Duncan
karen.duncan@terrapinn.com